Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Staphylococcus aureus Vaccine in Orthopedic Surgery Patients
CTR20181788Phase 2Completed
- Sponsor
- Yuanlun Biotechnology
- Start
- Nov 2018
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant five-antigen Staphylococcus aureus vaccine in Staphylococcus aureus infection, sponsored by Yuanlun Biotechnology. Started Nov 2018; status: completed.
02
Drugs
recombinant five-antigen Staphylococcus aureus vaccine
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on CTR20181788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181788.